US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 22, 2022 (4 years ago)

Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Raw material recalled by repackager, due to discoloration.

What was recalled

Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1

Recalling firm
Pine Pharmaceuticals, LLC
NDC code
69194-0948-1
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0130-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all